Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 21,169-21,180 of 23,847
Drug study icon
CompletedNCT00905307

Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for schizophrenia

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Device study icon
CompletedNCT03014544

Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery for depression

This study is completed in the United States. It is testing Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery for depression.

Multiple locations, including Birmingham
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 59 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.